Concepedia

K. Fizazi

KF

Statistics

Publications

2

Citations

25

H-Index

2

Active since

2024

Affiliations

Institut Gustave Roussy(Current)

K. Fizazi is an author at Institut Gustave Roussy specializing in prostate cancer, urology, and chemotherapy for prostate cancer.

Publications per year

2024–2024

2

Publications

2

PSMAddition: Phase 3 Trial of [177lu]Lu-PSMA-617 Plus Standard of Care (SoC) vs. Soc Alone in Patients with Metastatic Hormone-Sensitive Prostate Cancer

H. Kim, S.T. Tagawa, Oliver Sartor et al. · International Journal of Radiation Oncology*Biology*Physics · 2024 · 14 citations

, , +15

1654P TAMARACK: Randomized Phase II trial of the B7-H3 targeting antibody drug conjugate (ADC) vobramitamab duocarmazine (vobra duo) in metastatic castration-resistant prostate cancer (mCRPC)

J.S. de Bono, Carole Hélissey, K. Fizazi et al. · Annals of Oncology · 2024 · 11 citations

, , +17

1–2 of 2